Asploro Journal of Biomedical and Clinical Case Reports

Asploro Journal of Biomedical and Clinical Case Reports

Boon B^1*, De Praeter M², Jentjens S³, van Heerden J^4
1Department of Pediatrics, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium
²Department of Neurosurgery, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium
³Division of Nuclear Medicine, University Hospital Leuven, Leuven, Belgium
⁴Department of Pediatric Hematology and Oncology, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium

Corresponding Author: Bram Boon ^{ORCID ID}
Address: Department of Paediatrics, Gasthuiszusters Antwerpen, Sint-Vincentius Ziekenhuis, Sint-Vincentiusstraat 20, 2018 Antwerp, Belgium.
Received date: 15 October 2020; Accepted date: 07 November 2020; Published date: 14 November 2020

Citation: Boon B, De Praeter M, Jentjens S, van Heerden J. Focal Fibroadipose Overgrowth of the Forehead: A Case Report. Asp Biomed Clin Case Rep. 2020 Nov 14;3(3):234-40.

Copyright © 2020 Boon B, De Praeter M, Jentjens S, van Heerden J. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.

Keywords: Fibroadipose, Overgrowth, Adolescent Medicine

Abstract

This article describes a rare case of isolated focal fibroadipose overgrowth of the forehead in a 15-year-old patient. Various overgrowth syndromes were considered in the differential diagnosis, including Proteus syndrome, facial infiltrating lipomatosis, and macrodystrophia lipomatosa. The diagnosis is primarily based on clinical presentation and imaging modalities. However, for academic and supporting diagnostic purposes a biopsy is advised, yet may not be in the best interest of the patient. Management was conservative with future perspective for surgical management after cessation of growth.

Key Clinical Message

Focal fibroadipose overgrowth can be caused by various overgrowth syndromes. Accurately diagnosing these syndromes is important, since there are differences in preferred therapeutic management and follow-up, including the need for cancer surveillance. In isolated, limited, benign focal fibroadipose overgrowth, the benefits of an invasive biopsy might be outweighed by the possible risks.